<?xml version='1.0' encoding='utf-8'?>
<section xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>48-844.02</num>
  <heading>Definitions.</heading>
  <text>For the purposes of this chapter, the term:</text>
  <para>
    <num>(1)</num>
    <text>“Pharmaceutical product” shall have the same meaning as provided in § <cite path="§3-1201.02">3-1201.02</cite>(10A)(B)(iii).</text>
  </para>
  <para>
    <num>(2)</num>
    <text>“Practice of pharmaceutical detailing” shall have the same meaning as provided in § <cite path="§3-1201.02">3-1201.02</cite>(10A) [§ <cite path="§3-1201.02">3-1201.02</cite>(10A)(A)].</text>
  </para>
  <annotations>
    <annotation doc="D.C. Law 17-131" type="History">Mar. 26, 2008, D.C. Law 17-131, § 502, 55 DCR 1659</annotation>
  </annotations>
</section>
